Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001314282 | SCV001504809 | uncertain significance | Glucose-6-phosphate transport defect | 2024-10-31 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 315 of the SLC37A4 protein (p.Met315Thr). This variant is present in population databases (rs781834870, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SLC37A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1015427). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SLC37A4 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002476457 | SCV002781387 | uncertain significance | Phosphate transport defect; Glucose-6-phosphate transport defect; Congenital disorder of glycosylation, type IIw | 2022-02-10 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001314282 | SCV002078696 | uncertain significance | Glucose-6-phosphate transport defect | 2020-02-03 | no assertion criteria provided | clinical testing |